Evidence map›Paper›PMID 23167903›Full record

ArticleBreast cancer research : BCR2012

S-nitrosylation of Ras in breast cancer.

Harvey E Marshall, Matthew W Foster

Open access · goldAbstract readEditorialComment
In one paragraph

Article in Breast cancer research : BCR, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.3field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Nitric Oxide Signaling and Sensing in Age-Related Diseases.Antioxidants (Basel, Switzerland) · 2024
    Review
  2. Review
  3. Targeting Nitric Oxide: Say NO to Metastasis.Clinical cancer research : an official journal of the American Association for Cancer Research · 2023
    Review
  4. Review
  5. Review
  6. Review
  7. Review
  8. S-Nitrosylation in Tumor Microenvironment.International journal of molecular sciences · 2021
    Review
  9. Nitric Oxide and S-Nitrosylation in Cancers: Emphasis on Breast Cancer.Breast cancer : basic and clinical research · 2020
    Review
  10. S-Nitrosylation: An Emerging Paradigm of Redox Signaling.Antioxidants (Basel, Switzerland) · 2019
    Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Harvey E Marshall
Matthew W Foster
Duke Medical Center · USDuke University Hospital · US

Funding

S-nitrosothiols, NF-KappaB and Inflammation in Acute Lung InjuryR01HL092994 · NHLBI · DUKE UNIVERSITY · PI MARSHALL, HARVEY E · 2009 to 2017
$3.1M
S-nitrosothiol-regulated pathways in acute lung injuryR21HL106121 · NHLBI · DUKE UNIVERSITY · PI FOSTER, MATTHEW WOLF, MARSHALL, HARVEY E · 2011 to 2012
$391k
NHLBI NIH HHS HL092994NHLBI NIH HHS HL106121
6 · The paper itself

Abstract

Elevated expression of nitric oxide synthase 2 has been recently shown to correlate with poor survival in estrogen receptor-negative breast cancer. In an article in Breast Cancer Research, Switzer and colleagues identify the transcription factor Ets-1 as a critical mediator of nitric oxide-dependent oncogenic gene expression in basal-like breast cancer. This pathway is driven by S-nitrosylation of wild-type Ras, which leads to mitogen-activated protein kinase-dependent phosphorylation and activation of Ets-1. These results establish a new role for S-nitrosylation in mediating an aggressive breast cancer phenotype.

Indexed as

Signal TransductionBreast NeoplasmsFemaleHumansNitric OxideProto-Oncogene Protein c-ets-1Receptors, EstrogenNitric OxideProto-Oncogene Protein c-ets-1Receptors, Estrogen

Identifiers

PMID23167903
PMCPMC4053123
OpenAlexW2135903110

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.